Nectar Lifesciences Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1995. The current market capitalisation stands Rs 281 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 532649. and also listed on National Stock Exchange (NSE) with NSE code as NECLIFE.
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and Chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectables. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol and allied products, including menthol crystals, menthol flakes, peppermint oil, cis 3 hexenol, mentha piperita, Indian spearmint oil, menthones, mint blends, dementholised peppermint oil, and other customized mint based products. The was incorporated in 1995 and is headquartered in Chandigarh, India.